Literature DB >> 11074563

Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: report of an adult case and review of the literature.

A Lounici1, P Cony-Makhoul, P Dubus, F Lacombe, J P Merlio, J Reiffers.   

Abstract

Lineage switch from AML to ALL is an extremely rare phenomenon, and we report the case of an adult diagnosed with AML at 46 years of age who relapsed with ALL. At initial diagnosis, blast cell morphology and immunophenotyping were consistent with the diagnosis of M4-AML. Complete remission was achieved, and the patient underwent autologous BMT. At relapse, six months after ABMT, blast cells were different from those seen at initial diagnosis, for morphology (L2-ALL), cytochemistry, and immunophenotyping. The karyotype was normal at both diagnosis and relapse. No evidence of bcr-abl fusion genes was found by RT-PCR. Monoclonal IgH and TCR gamma gene rearrangement were evidenced by PCR analysis at relapse but not on blast cells at AML diagnosis. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11074563     DOI: 10.1002/1096-8652(200012)65:4<319::aid-ajh13>3.0.co;2-1

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.

Authors:  Mingqiang Ren; Haiyan Qin; Eiko Kitamura; John K Cowell
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

2.  Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia.

Authors:  Borae G Park; Chan-Jeoung Park; Seongsoo Jang; Eul Ju Seo; Hyun-Sook Chi; Jung-Hee Lee
Journal:  Korean J Lab Med       Date:  2011-04

3.  Tracing dynamics and clonal heterogeneity of Cbx7-induced leukemic stem cells by cellular barcoding.

Authors:  Karin Klauke; Mathilde J C Broekhuis; Ellen Weersing; Albertina Dethmers-Ausema; Martha Ritsema; Marta Vilà González; Erik Zwart; Leonid V Bystrykh; Gerald de Haan
Journal:  Stem Cell Reports       Date:  2014-11-26       Impact factor: 7.765

4.  First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Authors:  Claire Horgan; Charalampos Kartsios; Emmanouil Nikolousis; Paneesha Shankara; Bhuvan Kishore; Richard Lovell; Vidhya Murthy; Zbigniew Rudzki; Sara Dyer; Pam Holtom; Gillian Thompson; Maria Kaparou; Evgenia Xenou; Rebecca Lloyd; Indrani Venkatadasari; Alexandros Georgios Kanellopoulos
Journal:  Leuk Res Rep       Date:  2020-06-18

5.  A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia.

Authors:  Sufana Shikdar; Yuan Ying; Mohamad Khawandanah
Journal:  Leuk Res Rep       Date:  2022-03-01

6.  Lineage switch from lymphoma to myeloid neoplasms: First case series from a single institution.

Authors:  Wenjuan Yang; Shuangfeng Xie; Yiqing Li; Jieyu Wang; Jie Xiao; Kezhi Huang; Xiuju Wang; Yudan Wu; Liping Ma; Danian Nie
Journal:  Open Med (Wars)       Date:  2022-09-08

7.  CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.

Authors:  Elad Jacoby; Sang M Nguyen; Thomas J Fountaine; Kathryn Welp; Berkley Gryder; Haiying Qin; Yinmeng Yang; Christopher D Chien; Alix E Seif; Haiyan Lei; Young K Song; Javed Khan; Daniel W Lee; Crystal L Mackall; Rebecca A Gardner; Michael C Jensen; Jack F Shern; Terry J Fry
Journal:  Nat Commun       Date:  2016-07-27       Impact factor: 14.919

Review 8.  Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia.

Authors:  Tianyuan Hu; Rebecca Murdaugh; Daisuke Nakada
Journal:  Front Oncol       Date:  2017-11-06       Impact factor: 6.244

9.  A case report of lineage switch from T-cell acute leukemia to B-cell acute leukemia.

Authors:  Yejing Zhu; Hui Liu; Shuna Zhang; Yanyan Liang; Meng Xiao; Yunliang Hao; Yun Guan
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.